Fed Minutes Reveal Rate-Hike Split as Warsh Skips His First Dot Plot

The Fed's June minutes expose a nine-to-eight split toward rate hikes under new Chair Kevin Warsh, PepsiCo misses on earnings as U.S. shoppers pull back, AstraZeneca loses roughly £19 billion after its Wainua heart drug trial fails, and China's consumer prices cool while factory-gate costs hit a four-year high. In this episode: • Federal Reserve minutes reveal division over rate direction at June meeting — https://www.cnbc.com/2026/07/08/fed-minutes-june-2026-.html • PepsiCo shares fall as earnings miss estimates on tightening U.S. consumer budgets — https://www.cnbc.com/2026/07/09/pepsico-pep-q2-2026-earnings.html • AstraZeneca stock drops 9% after major heart drug trial misses key goals — https://www.cnbc.com/2026/07/09/astrazeneca-stock-trial-heart-drug-pharma.html • China consumer inflation weakens in June while producer costs climb — https://www.cnbc.com/2026/07/09/china-cpi-ppi-june-inflation-iran-war-.html